
Cutiss AG
Personalized bio-engineered tissue therapy to transform skin surgery
We are a Swiss emerging company focusing on innovation in regenerative medicine. Our first focus is to provide patients who suffer from large skin injuries and defects with personalized skin tissue therapy in a safe, effective and accessible manner.
Production
CUTISS manufactures its lead product for clinical use in its state of the art, certified Good Manufacturing Practice Facility.

Automation
CUTISS has developed first-in-class machine for the automated
production of tissue therapy.
Blog
5 questions for our co-founder Fabienne in IngFLASH
26. September 2023
Nasdaq recognition
12. April 2023
What can Switzerland do to better nurture startups?
27. June 2022
Life after a severe burn accident
23. November 2021
CUTISS co-founders in Swiss Venture Club podcast
30. September 2021